Joint Scientific Meeting selected the most innovative solutions in transplant care from twenty-five submissions across Canada in the 2017 T3 (Transformative Thinking in Transplant) Competition and granted the winners a gross of one-hundred thousand dollars. The objective of the T3 Competition is to identify and provide plausible implementation solutions in the areas of patient care, education, adherence, organ donation, quality of life improvement with the goal of advancing long-term health outcomes and quality of life for Canadian transplant patients.
Kevin Wen received first place grant of fifty-thousand dollars with, “The One App to Rule Them All”, a smartphone app designed for the use by both transplant recipients and HCP to improve immunosuppressive medication adherence and communication.
The second prize and third prize finalists also received twenty-five thousand dollars each for their innovative transplant ideas. Mark Belan on behalf of Christine Ribic featured, “TransPLANTS: An Animated Guide to Renal Transplantation”, created to increase health literacy through an innovative and educational animation module for patients referred to renal transplantation. Chia Wei Teoh displayed the, “My Transplant Buddy App”, that plans to improve kidney transplant outcomes for children and their families.
The competition was funded by a grant from Astellas Pharma Canada and was designed by and for the transplant community to encourage ground-breaking solutions in transplant care and quality of life improvement. The judges were comprised of the transplant community and sought-after projects and ideas that advanced health outcomes in transplant care.
“The advancements we have seen in transplantation over the last number of years are largely due to the expertise, insight, and dedication of the men and women who work in the field,” said Milka Lukovich, director, hospital business unit for Astellas Pharma Canada. “Tonight was about recognizing these individuals – from the transplant surgeons and physicians, to the coordinators, nurses, pharmacists, social workers, dieticians and other healthcare professionals. As Astellas marks twenty years of innovation in immunosuppressive therapy in Canada, we could not think of a better time to provide support to the CST in advancing the kind of innovation that will impact the patients and their families who are at the core of everything we do,” she concluded.
The competition was open to members of the Canadian Society of Transplantation, the professional organization that includes physicians, surgeons and other healthcare professionals who work in transplantation.
“We are justifiably proud of Canada’s many accomplishments in advancing transplantation both here and globally, but tonight gives us even more reason to be enthusiastic and hopeful for the future,” said Atul Humar, president of the CST. “Today, more than four-thousand five-hundred Canadians are reportedly on the waiting list for a solid organ donation and thanks to advances in medical science the number of organ transplants increased overall by twenty-three percent over the last 10 years. In partnering with Astellas on the T3 Competition, the Canadian Society of Transplantation has gone beyond the expected to explore new and different ways that we can be the catalysts of change.”